sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Middle East and Africa Virus-like Particles Market...

2028年までの中東およびアフリカのウイルス様粒子市場予測 - 製品タイプ別（肝炎、がん/HPV、ゴーシェ病）、発生源（酵母、昆虫細胞、植物など）、用途別の新型コロナウイルス感染症の影響と地域分析(ワクチンと治療薬)

TIPRE00026830 | Pages: 117 | Pharmaceuticals | Jan 2022 | Type: Regional | Status: Published

市場紹介

アラブ首長国連邦 (UAE)、サウジアラビア、南アフリカは、中東および主要国アフリカ地域。サウジアラビアは、2021 年にこの地域におけるウイルス様粒子の最大の市場でした。アフリカ サウジアラビアは、予測期間中により高い CAGR で成長すると予想されます。この成長は、さまざまな病気の有病率の上昇と、資金提供や医療関連政策に関する政府の取り組みの増加によるものと考えられます。

経済的不確実性と進行中の紛争により、この地域の状況は悪化しています。 。たとえば、シリア、リビア、イエメンなどの国々は暴力的な紛争に苦しんでおり、公衆衛生対策を講じることができません。イランは米国の制裁により深刻な経済不況に陥っていた。さらに、財政状況の逼迫により、地域の経済活動も縮小しています。多くの国がこの地域で新型コロナウイルス感染症（COVID19）ワクチンの不足に直面している。地域のさまざまな発展途上先進国では、新型コロナウイルス感染症ワクチンの供給が遅れている。したがって、世界のワクチン製造業者が中東アフリカの未開発地域を開拓する可能性がある。例えば、2021年8月にブルッキングス研究所で発表されたデータによれば、中東アフリカの低・中所得国におけるワクチン接種率はヨルダン25％、モロッコ27％と推定されているが、中東アフリカのどの国もワクチン接種を行っていない。人口の15％以上に1回のワクチン接種を提供することができます。したがって、この地域の VLP 関連市場に潜在的な市場を提供し、この地域の VLP 市場にプラスの影響を与えます。

市場の概要とダイナミクス

市場の概要とダイナミクス

u>

中東および日本におけるウイルス様粒子市場アフリカは2021年の1億5,283万米ドルから2028年までに2億4,912万米ドルに成長すると予想されています。 2021 年から 2028 年までに 7.2% の CAGR で成長すると推定されています。ヘルスケア市場のさまざまなプレーヤーや研究機関が製品の革新と開発に積極的に関わっています。ウイルス様粒子の使用は、バイオ医薬品業界で使用される新たなアプローチです。ウイルス様粒子にはウイルス成分が含まれていないため、実際のウイルス成分よりも扱いが容易です。 VLP は、ドラッグデリバリー、イメージング、免疫療法、および治療の補助に使用できます。例えば、2020年6月にNCBIに発表された研究によれば、VLPは光熱療法、PETおよびCTイメージング、MRI造影剤担体、光学イメージング、炎症性および自己免疫疾患ワクチン、がん免疫療法、および小分子薬物送達（がん治療における）。したがって、VLP のこのような潜在的なアプリケーションは、予測期間中に市場参加者に成長の機会を提供すると予想されます。

主要市場セグメント

製品の種類に関しては、肝炎セグメントが中東および地域で最大のシェアを占めました。 2021年のアフリカのウイルス様粒子市場。ソースに関しては、酵母セグメントが中東およびアフリカで最大のシェアを占めた。 2021 年のアフリカのウイルス様粒子市場。アプリケーションの観点から見ると、2021 年のウイルス様粒子市場ではワクチン部門がより大きな市場シェアを占めました。

主要な情報源と企業のリスト

中東のウイルス様粒子市場に関するこのレポートを作成するために参照したいくつかの主要な一次および二次情報源イースト&アフリカには、企業のウェブサイト、年次報告書、財務報告書、国家政府の文書、統計データベースなどが含まれます。レポートに記載されている主要企業は、Merck & Ltd.です。株式会社;グラクソ・スミスクライン社;ファイザー株式会社;サノフィ;インド血清研究所株式会社;バーラト・バイオテック。 LG化学;

購入理由レポート

  • 中東と世界を理解するにはアフリカのウイルス様粒子市場の状況を把握し、高い収益を保証する可能性が最も高い市場セグメントを特定する
  • 刻々と変化する中東の競争環境を理解することで、競争に先んじる&アフリカのウイルス様粒子市場
  • 中東およびアフリカでの M&A および提携取引を効率的に計画最も売上が見込まれる市場セグメントを特定することにより、アフリカのウイルス様粒子市場
  • 中東のさまざまなセグメントの市場パフォーマンスの知覚的かつ包括的な分析から、知識に基づいたビジネス上の意思決定を行うのに役立ちます&アフリカのウイルス様粒子市場
  • 中東およびアフリカの2021年から2028年までのさまざまなセグメント別の市場収益予測を入手します。アフリカ地域。

中東および地域。アフリカのウイルス様粒子市場のセグメンテーション

 

<スパン><スパン>中東とアフリカのウイルス様粒子市場 - 製品タイプ別

  • 肝炎
  • がん/HPV
  • ゴーシェ病

中東およびHPVアフリカのウイルス様粒子市場 - 発生源別

  • 酵母
  • 昆虫セル
  • 植物
  • その他

<強い>中東とアフリカのウイルス様粒子市場 - アプリケーション

  • ワクチン
  • 治療学

中東と治療学アフリカのウイルス様粒子市場 - 国

  • サウジアラビア別
  • 南アフリカ
  • アラブ首長国連邦
  • MEA の残りの部分   ;   

中東とアフリカのウイルス様粒子市場 - 言及された企業

  • Merck &株式会社                        ;                       &nバスプ;       
  • GlaxoSmithKline plc.
  • ファイザー株式会社  ;                       &nバスプ;                       &nバスプ;                  
  • サノフィ                                    ;                           ;                
  • インド血清研究所 Pvt.株式会社                            
  • BHARAT BIOTECH               ;                       &nバスプ;               
  • LG 化学                                                  ;                      
  • VBI ワクチン株式会社                                              ;           

1.            Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Virus-like Particles Market – By Product Type

1.3.2        Middle East & Africa Virus-like Particles Market – By Source

1.3.3        Middle East & Africa Virus-like Particles Market – By Application

1.3.4        Middle East & Africa Virus-like Particles Market – By Country

2.           Middle East & Africa Virus-like Particles Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East & Africa Virus-like Particles Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           Middle East & Africa Virus-like Particles Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Higher Prevalence of Infectious Viral Diseases

5.1.2        Fostering Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2         Market Restraints

5.2.1        Existence of Alternative Technologies for Viral Vaccine Production

5.3         Market Opportunities

5.3.1        Increasing Potential Applications in Therapeutics and Diagnostics

5.4         Future Trends

5.4.1        Regular Demand for Innovative and Effective Products

5.5         Impact Analysis

6.           Middle East & Africa Virus-like Particles Market Analysis

6.1         Middle East & Africa Virus-like Particles Market Revenue Forecast and Analysis

7.           Middle East & Africa Virus-like Particles Market Analysis – by Product Type

7.1         Overview

7.2         Middle East & Africa Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3         Hepatitis

7.3.1        Overview

7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4         Cancer/ Human Papillomavirus (HPV)

7.4.1        Overview

7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5         Gaucher Disease

7.5.1        Overview

7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.           Middle East & Africa Virus-like Particles Market Analysis – By Source

8.1         Overview

8.2         Middle East & Africa Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3         Yeast

8.3.1        Overview

8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4         Plant

8.4.1        Overview

8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5         Insect Cell

8.5.1        Overview

8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.           Middle East & Africa Virus-like Particles Market Analysis – By Application

9.1         Overview

9.2         Middle East & Africa Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3         Vaccines

9.3.1        Overview

9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4         Therapeutics

9.4.1        Overview

9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.        Middle East & Africa Virus-like Particles Market – Country Analysis

10.1      Overview

10.1.1     Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

10.1.1.1       UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4       UAE: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.1.5       UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4       Saudi Arabia: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.2.5       Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       South Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4       South Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.3.5       South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4       Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       Overview

10.1.1.4.2       Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3       Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4       Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.4.5       Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on Middle East & Africa Virus-like Particles Market

11.1      Impact Assessment of COVID-19 Pandemic

12.        Middle East & Africa Virus-like Particles Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Merck & Co., Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Sanofi

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Serum Institute of India Pvt. Ltd.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      BHARAT BIOTECH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      LG Chem

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      VBI Vaccines Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Middle East & Africa Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2.             UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 3.             UAE Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 4.             UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5.             Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 6.             Saudi Arabia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 7.             Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8.             South Africa Virus-like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

Table 9.             South Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 10.          South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11.          Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 12.          Rest of Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 13.          Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 14.          Organic Developments Done by Companies

Table 15.          Inorganic Developments Done by Companies

Table 16.          Glossary of Terms: Virus-like Particles Market

 


LIST OF FIGURES

Figure 1.           Middle East & Africa Virus-like particles Market Segmentation

Figure 2.           Middle East & Africa Virus-like particles Market Segmentation, By Country

Figure 3.           Middle East & Africa Virus-like Particles Market Overview

Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in Middle East & Africa Virus-like particles Market

Figure 5.           Saudi Arabia to Show Significant Growth during Forecast Period

Figure 6.           Middle East & Africa Virus-like Particles Market, Industry Landscape

Figure 7.           Middle East & Africa PEST Analysis

Figure 8.           Middle East & Africa Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9.           Middle East & Africa Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10.        Middle East & Africa Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Middle East & Africa Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Middle East & Africa Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Middle East & Africa Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 23.        Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

Figure 24.        UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Impact Of COVID-19 Pandemic in Middle East & African Countries

  1. Merck & Co., Inc.                                                       
  2. GlaxoSmithKline plc.                                                
  3. Pfizer Inc.                                                                    
  4. Sanofi                                                                         
  5. Serum Institute of India Pvt. Ltd.                           
  6. BHARAT BIOTECH                                                      
  7. LG Chem                                                                     
  8. VBI Vaccines Inc.                                                       
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa virus-like particles market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S.. May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En.. May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription